Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 1
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

4 results
Results by year
Filters applied: . Clear all Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Reasons for switching to fingolimod in patients relapsing-remitting multiple sclerosis in France: the ESGILE study.
Tourbah A, Papeix C, Tourniaire P, Rerat K, Meite M, Durand B, Lamy F, Chouette I, Mekies C; ESGILE Study Group. Tourbah A, et al. Mult Scler Relat Disord. 2020 Nov;46:102433. doi: 10.1016/j.msard.2020.102433. Epub 2020 Jul 30. Mult Scler Relat Disord. 2020. PMID: 32862037
Physicians documented clinical status by relapse activity, disability (EDSS) at each visit and improvement with the Clinical Global Impression - Change (CGI-C) at Month 12. Patients rated improvement at Month 12 with the Patient Global Impression - Change (PGI-C) an …
Physicians documented clinical status by relapse activity, disability (EDSS) at each visit and improvement with the Clinical Global Impressi …
PSMA-positive nodal recurrence in prostate cancer : Salvage radiotherapy is superior to salvage lymph node dissection in retrospective analysis.
Schmidt-Hegemann NS, Buchner A, Eze C, Rogowski P, Schaefer C, Ilhan H, Li M, Fendler WP, Bartenstein P, Ganswindt U, Stief C, Belka C, Kretschmer A. Schmidt-Hegemann NS, et al. Strahlenther Onkol. 2020 Jul;196(7):637-646. doi: 10.1007/s00066-020-01605-z. Epub 2020 Mar 24. Strahlenther Onkol. 2020. PMID: 32211942 Free PMC article.
One-day prevalence of asymptomatic carriage of toxigenic and non-toxigenic Clostridioides difficile in 10 French hospitals.
Le Monnier A, Candela T, Mizrahi A, Bille E, Bourgeois-Nicolaos N, Cattoir V, Farfour E, Grall I, Lecointe D, Limelette A, Marcade G, Poilane I, Poupy P, Kansau I, Zahar JR, Pilmis B; GMC group. Le Monnier A, et al. J Hosp Infect. 2022 May 28:S0195-6701(22)00162-1. doi: 10.1016/j.jhin.2022.05.011. Online ahead of print. J Hosp Infect. 2022. PMID: 35640734
The median of age was 73 years [range min-max: 18-101] and the sex M/F ratio was 1.06. C. difficile (either toxigenic or non-toxigenic strains) was isolated from 79 (11%) patients, including 42 (5.8%) with toxigenic strains. ...The main risk factors associated with asympto …
The median of age was 73 years [range min-max: 18-101] and the sex M/F ratio was 1.06. C. difficile (either toxigenic or non-toxigeni …
Tackling the COVID-19 pandemic: Initial responses in 2020 in selected social health insurance countries in Europe.
Schmidt AE, Merkur S, Haindl A, Gerkens S, Gandré C, Or Z, Groenewegen P, Kroneman M, de Jong J, Albreht T, Vracko P, Mantwill S, Hernández-Quevedo C, Quentin W, Webb E, Winkelmann J. Schmidt AE, et al. Health Policy. 2022 May;126(5):476-484. doi: 10.1016/j.healthpol.2021.09.011. Epub 2021 Sep 29. Health Policy. 2022. PMID: 34627633 Free PMC article.